Overcoming the Testing Blind Spot: A Safer Approach to Diagnosis

By Professor Kevin Moore

Up to 70% of clinical decisions rely on pathology results, yet pre-analytical errors before samples even reach the analyser continue to slip through the cracks. 

Establishing end-to-end accountability across collection and transport protects specimen integrity, reduces repeat testing, and closes the critical gap between phlebotomy and the laboratory.


About the Author

Dr.Kevin Moore is a Liver Expert for the Courts, where he provides an independent opinion on the care provided by other doctors. As a Professor of Hepatology and Clinical Pharmacologist at University College London, his expertise in drug safety monitoring and adherence to national guidelines provides a unique perspective on the healthcare system's successes and failures. With over two decades of specialized experience in liver transplantation and general hepatology, he brings substantial clinical and academic authority to both patient care and medical-legal evaluations, along with a keen understanding of the practical challenges facing modern healthcare delivery.   

Kevin Moore at UCL, Royal Free has authored over 100 research papers with an H index of 64 and is the author of the Oxford Handbook of Acute Medicine.

Time to be healthcareful®

Next
Next

The Real Cost of MDT Delays on Patient Safety